IMPAKT 2014: Abstract Submission
IMPAKT 2014 is THE European conference focusing on translational research in breast cancer – a unique platform on which to share your research with an expert audience of scientists and clinicians.
Established by some of the most important organisations in breast cancer, the intimate size of the event stimulates discussion and interaction between participants. Take advantage of this perfect networking environment to disseminate your study to an audience of leading breast cancer experts.
Abstract submission for IMPAKT 2014 closed on 15 January 2014.
Abstract submission deadline
|Deadline||Date & Time|
|Abstracts||Wednesday 15 January 2014, 23:59 CET|
Abstract submission categories
|IMPAKT 2014 abstract categories|
|Detection and diagnosis||Early breast cancer systemic therapy|
|Loco-regional therapy||Advanced breast cancer systemic therapy|
|Genomics and proteomic analysis of breast cancer||Biomarkers in breast cancer (prognostic, predictive and pharmacodynamic)|
|Breast cancer host immune and stromal biology||Imaging (preclinical and clinical)|
|Preclinical breast cancer biology||Computational biology|
|Breast cancer target identification and validation and preclinical models||New drug development|
All accepted abstracts will be published online as a supplement of the official ESMO journal, Annals of Oncology.
A restricted number of travel grants to the Conference will be available. Selection of travel grant recipients will be made by the Scientific Committee on a competitive basis from among the accepted abstracts submitted by candidates aged 40 years or younger. In addition to travel subsidies and accommodation, travel grant recipients will receive free registration to both the Conference and the pre-IMPAKT training course. Please see our Frequently Asked Questions page for further information.